Physician profile
Allison Joye Loftus
NPI 1497222541
$8,731.58
in general payments reported to CMS, 2019-2025
39 companies · $2,185 in 2025
The $2,185 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,168 · 2022: $1,756 · 2023: $1,990 · 2024: $1,633 · 2025: $2,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,609 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,609.44 |
| Education | $198.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,821.54 | 2021-2025 | Provenge |
| Janssen Biotech, INC. | $927.73 | 2021-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $913.59 | 2021-2025 | Xtandi |
| Pfizer INC. | $713.45 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $521.25 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $471.21 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $428.47 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Abbvie INC. | $425.62 | 2021-2025 | |
| Blue Earth Diagnostics | $323.65 | 2021-2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $320.78 | 2021-2025 | Lynparza |
| C. R. Bard, INC. & Subsidiaries | $212.02 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Sumitomo Pharma America, INC. | $205.32 | 2023-2025 | Orgovyx, Gemtesa |
| Progenics Pharmaceuticals, INC. | $177.90 | 2021-2024 | Pylarify |
| Tolmar, INC. | $171.29 | 2023-2025 | Jatenzo, Eligard, Rubraca |
| Urogen Pharma, INC. | $121.83 | 2021-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $115.78 | 2021-2023 | Prolia, Xgeva |
| Myovant Sciences INC. | $103.46 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $96.71 | 2021-2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $92.57 | 2022-2025 | Yonsa |
| Becton, Dickinson and Company | $89.01 | 2023-2024 | Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $52.54 | 2022-2025 | Spaceoar Vue System - 10ml |
| Caris Mpi, INC. | $40.17 | 2025 | Mi Cancer Seek |
| Tolmar Pharmaceuticals, INC. | $36.60 | 2022 | |
| Pharmaand Gmbh | $35.70 | 2024-2025 | Rubraca |
| Procept Biorobotics Corporation | $35.04 | 2022-2024 | Aquabeam System |
| Teleflex LLC | $31.97 | 2021-2022 | |
| Eisai INC. | $25.56 | 2021-2022 | |
| Tempus Ai, INC | $24.53 | 2024 | |
| Axonics, INC. | $22.75 | 2024 | Bulkamid |
| Clarus Therapeutics INC. | $22.72 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $21.59 | 2025 | |
| Calyxo, INC. | $20.17 | 2025 | Cvac Aspiration System |
| Telix Pharmaceuticals | $18.70 | 2023 | Illuccix |
| Azurity Pharmaceuticals, INC. | $17.45 | 2025 | Azmiro |
| Menarini Silicon Biosystems, INC. | $16.68 | 2025 | Cellsearch |
| Olympus America INC. | $16.32 | 2025 | Itind System |
| Coloplast Corp | $15.07 | 2023 | Stenostent |
| Myriad Genetic Laboratories, INC. | $12.99 | 2021 | |
| Foundation Medicine, INC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Loftus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.